| Code | 9105B | ||||||||||
| MA number | 27/0222/16-S | ||||||||||
| Product Form: | tbl flm 100x150 mg/37,5 mg/200 mg (blis.Al/Al) | ||||||||||
| MA Status: | D - Marketing Authorisation valid for an unlimited period | ||||||||||
| Type of procedure: | Decentralised | ||||||||||
| MAH, country: | GL Pharma GmbH, Austria | ||||||||||
| Therapeutic Class: | 27 - ANTIPARKINSONICA | ||||||||||
| ATC: |
|
||||||||||
| Shelf life: | 36 | ||||||||||
| Route of admin.: | Oral use |
| Prescription Status: | Medicinal product subject to medical prescription. |
| Legal basis: | Article 10(1) generic application |
| MA issued: | 21.04.2016 |
| PIL: |
PIL_Trigelan_10.2020.doc
|
| SPC: |
SPC_Trigelan_50mg-12,5mg-200mg_100mg-25mg-200mg_150mg-37,5mg-200mg_200mg-50mg-200mg_filmom obalené tablety_09.2025.pdf
|
| Safety feature | Yes |
| Data update: | 14.10.2025 |
